甲状腺未分化がん治療薬市場は2023年から2028年に3億70万米ドル、予測期間中のCAGRは6.41%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。甲状腺がんの高い有病率、標的療法の導入、老年人口の増加が市場を牽引しています。
本調査では、今後数年間の甲状腺未分化がん治療薬市場成長を牽引する主要因の1つとして、甲状腺がんに対する意識の高まりを挙げています。また、甲状腺未分化がんの治療における強力なパイプラインと化学療法に対する有利な償還政策が市場の大きな需要につながっています。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global anaplastic thyroid cancer drugs market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global anaplastic thyroid cancer drugs market 2018 - 2022 ($ million)
4.2 End-user Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - product Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Hospitals - Market size and forecast 2023-2028
Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
6.4 Clinics - Market size and forecast 2023-2028
Exhibit 38: Chart on Clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Clinics - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ million)
Exhibit 47: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Product
7.1 Market segments
Exhibit 48: Chart on Product - Market share 2023-2028 (%)
Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 50: Chart on Comparison by Product
Exhibit 51: Data Table on Comparison by Product
7.3 Chemotherapy - Market size and forecast 2023-2028
Exhibit 52: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
7.4 Novel therapy - Market size and forecast 2023-2028
Exhibit 56: Chart on Novel therapy - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Novel therapy - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Novel therapy - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Novel therapy - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Product
Exhibit 60: Market opportunity by Product ($ million)
Exhibit 61: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Italy - Market size and forecast 2023-2028
Exhibit 87: Chart on Italy - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Italy - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Italy - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Italy - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 India - Market size and forecast 2023-2028
Exhibit 99: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on India - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Bayer AG
Exhibit 111: Bayer AG - Overview
Exhibit 112: Bayer AG - Business segments
Exhibit 113: Bayer AG - Key news
Exhibit 114: Bayer AG - Key offerings
Exhibit 115: Bayer AG - Segment focus
12.4 Bristol Myers Squibb Co.
Exhibit 116: Bristol Myers Squibb Co. - Overview
Exhibit 117: Bristol Myers Squibb Co. - Product / Service
Exhibit 118: Bristol Myers Squibb Co. - Key news
Exhibit 119: Bristol Myers Squibb Co. - Key offerings
12.5 Daiichi Sankyo Co. Ltd.
Exhibit 120: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 121: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibit 122: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 123: Daiichi Sankyo Co. Ltd. - Key offerings
12.6 Eisai Co. Ltd.
Exhibit 124: Eisai Co. Ltd. - Overview
Exhibit 125: Eisai Co. Ltd. - Business segments
Exhibit 126: Eisai Co. Ltd. - Key offerings
Exhibit 127: Eisai Co. Ltd. - Segment focus
12.7 Exelixis Inc.
Exhibit 128: Exelixis Inc. - Overview
Exhibit 129: Exelixis Inc. - Product / Service
Exhibit 130: Exelixis Inc. - Key offerings
12.8 Merck KGaA
Exhibit 131: Merck KGaA - Overview
Exhibit 132: Merck KGaA - Business segments
Exhibit 133: Merck KGaA - Key news
Exhibit 134: Merck KGaA - Key offerings
Exhibit 135: Merck KGaA - Segment focus
12.9 Novartis AG
Exhibit 136: Novartis AG - Overview
Exhibit 137: Novartis AG - Business segments
Exhibit 138: Novartis AG - Key offerings
Exhibit 139: Novartis AG - Segment focus
12.10 Verastem Inc.
Exhibit 140: Verastem Inc. - Overview
Exhibit 141: Verastem Inc. - Product / Service
Exhibit 142: Verastem Inc. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 143: Inclusions checklist
Exhibit 144: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 145: Currency conversion rates for US$
13.4 Research methodology
Exhibit 146: Research methodology
Exhibit 147: Validation techniques employed for market sizing
Exhibit 148: Information sources
13.5 List of abbreviations
Exhibit 149: List of abbreviations
